Simple animal models for amyotrophic lateral sclerosis drug discovery.

Abstract : Simple animal models have enabled great progress in uncovering the disease mechanisms of amyotrophic lateral sclerosis (ALS) and are helping in the selection of therapeutic compounds through chemical genetic approaches. Within this article, the authors provide a concise overview of simple model organisms, C. elegans, Drosophila and zebrafish, which have been employed to study ALS and discuss their value to ALS drug discovery. In particular, the authors focus on innovative chemical screens that have established simple organisms as important models for ALS drug discovery. There are several advantages of using simple animal model organisms to accelerate drug discovery for ALS. It is the authors' particular belief that the amenability of simple animal models to various genetic manipulations, the availability of a wide range of transgenic strains for labelling motoneurons and other cell types, combined with live imaging and chemical screens should allow for new detailed studies elucidating early pathological processes in ALS and subsequent drug and target discovery.
Type de document :
Article dans une revue
Expert Opinion on Drug Discovery, Informa Healthcare, 2016, 11 (8), pp.797-804. 〈10.1080/17460441.2016.1196183 〉
Liste complète des métadonnées

https://hal-riip.archives-ouvertes.fr/pasteur-01351530
Contributeur : Michel Courcelles <>
Soumis le : mercredi 3 août 2016 - 20:39:32
Dernière modification le : jeudi 20 septembre 2018 - 13:16:05

Identifiants

Collections

Citation

Shunmoogum A Patten, J Alex Parker, Xiao-Yan Wen, Pierre Drapeau. Simple animal models for amyotrophic lateral sclerosis drug discovery.. Expert Opinion on Drug Discovery, Informa Healthcare, 2016, 11 (8), pp.797-804. 〈10.1080/17460441.2016.1196183 〉. 〈pasteur-01351530〉

Partager

Métriques

Consultations de la notice

30